We are live on ! Find out more
VTGN icon

VistaGen Therapeutics
VTGN

101 hedge funds and large institutions have $387M invested in VistaGen Therapeutics in 2021 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 23 increasing their positions, 22 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

142% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 19

71% more capital invested

Capital invested by funds: $227M → $387M (+$160M)

36% more funds holding

Funds holding: 74 → 101 (+27)

5% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 22

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.31% less ownership

Funds ownership: 2.46% → 2.15% (-0.31%)

Holders
101
Holders Change
+27
Holders Change %
+36.49%
% of All Funds
1.76%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
46
Increased
23
Reduced
22
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$22.2M
2
O
OrbiMed
New York
+$14.5M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$7.6M
4
State Street
State Street
Massachusetts
+$7.56M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$4.88M

Top Sellers

Rank Fund Capital Flow
1
MWNA
Marshall Wace North America
New York
-$6.02M
2
GTC
Ghost Tree Capital
New York
-$5.29M
3
IC
Ikarian Capital
Texas
-$4.86M
4
Millennium Management
Millennium Management
New York
-$3.01M
5
SB
Samsara BioCapital
California
-$2.71M
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
76
Osaic Holdings
Arizona
$44K -$389K -5,248 -92%
Carson Wealth (CWM LLC)
77
Carson Wealth (CWM LLC)
Nebraska
$43K – – –
JWM
78
Jackson Wealth Management
Florida
$42K +$33K +446 New
Royal Bank of Canada
79
Royal Bank of Canada
Ontario, Canada
$41K +$32.5K +438 New
Prudential Financial
80
Prudential Financial
New Jersey
$39K +$31K +418 New
Citadel Advisors
81
Citadel Advisors
Florida
$38K -$238K -3,208 -89%
PPA
82
Parametric Portfolio Associates
Washington
$38K +$29.8K +402 New
William Blair & Company
83
William Blair & Company
Illinois
$38K +$30.2K +407 New
X
84
Xponance
Pennsylvania
$33K +$25.9K +349 New
NAS
85
Nicolet Advisory Services
Wisconsin
$32K – – –
CF
86
Centaurus Financial
California
$32K +$296 +4 +1%
Citigroup
87
Citigroup
New York
$29K -$107K -1,438 -83%
BNP Paribas Financial Markets
88
BNP Paribas Financial Markets
France
$23.2K +$18.2K +246 New
CAPTRUST Financial Advisors
89
CAPTRUST Financial Advisors
North Carolina
$16K +$12.4K +167 New
Fidelity Investments
90
Fidelity Investments
Massachusetts
$8K +$6.15K +83 New
Bank of America
91
Bank of America
North Carolina
$7K +$5.71K +77 New
GRP
92
Global Retirement Partners
California
$6K +$4.96K +67 New
TRCT
93
Tower Research Capital (TRC)
New York
$5K -$106K -1,436 -97%
PLU
94
Performa Ltd (US)
South Carolina
$5K +$4.22K +57 New
PSIWM
95
Paradigm Strategies in Wealth Management
Minnesota
$3K +$2.44K +33 New
AWM
96
Atticus Wealth Management
Florida
$2K -$4.96K -67 -74%
SCM
97
Silverarc Capital Management
Massachusetts
$1.94K +$1.52M +20,518 New
UBS Group
98
UBS Group
Switzerland
$1K -$26.1K -352 -98%
AIG
99
American International Group
New York
$338 +$265K +3,573 New
MWNA
100
Marshall Wace North America
New York
– -$6.02M -94,282 Closed
1 2 3
4
5

VTGN Hedge Fund Activity: Q2 2021 in Review

101 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in VistaGen Therapeutics (VTGN) for Q2 2021, worth a combined $387M — up 71% from $227M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new VTGN positions and 19 closed out — a net gain of 27 holders — while 23 added to existing stakes and 22 trimmed.

The largest buyer was BlackRock, adding an estimated $22.2M. The largest seller was Marshall Wace North America, exiting entirely with an estimated $6.02M sold.

  • 101 institutional investors held VistaGen Therapeutics (VTGN) as of Q2 2021, up from 74 in Q1 2021.
  • Funds reported $387M of VistaGen Therapeutics stock for Q2 2021, up 71% quarter-over-quarter.
  • 46 funds opened new VistaGen Therapeutics positions in Q2 2021 and 19 closed out, a net change of +27 holders.
  • The largest VistaGen Therapeutics buyer in Q2 2021 was BlackRock, an estimated $22.2M added.
  • The largest VistaGen Therapeutics seller in Q2 2021 was Marshall Wace North America, an estimated $6.02M sold.

Based on aggregated 13F filings for Q2 2021.